Synergy between human monoclonal antibodies to HIV extends their effective biologic activity against homologous and divergent strains.
Buchbinder
A
A
New York University Medical Center, New York 10010.
Zolla-Pazner
S
S
Karwowska
S
S
Gorny
M K
MK
Burda
S T
ST
D000911:Antibodies, Monoclonal / Q000276:immunology*; D003429:Cross Reactions; D015483:HIV Antibodies / Q000276:immunology*; D015699:HIV Envelope Protein gp120 / Q000276:immunology; D015497:HIV-1 / Q000145:classification / Q000276:immunology*; D006801:Humans; D009500:Neutralization Tests; D010446:Peptide Fragments / Q000276:immunology
D000911:Antibodies, Monoclonal; D015483:HIV Antibodies; D015699:HIV Envelope Protein gp120; C059762:HIV envelope protein gp120 (305-321); D010446:Peptide Fragments